ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
With the following Strong-Buy-rated health stocks (ABT, DHR, and DXCM), investors may just be able to get growth, relative defensiveness, and decent multiples as we head into May 2024. Undoubtedly, investors may wish to come for the underestimated growth and stay for their ability to move higher, even as the market tides turn against most stocks in the market. Therefore, in this piece, we'll check in with TipRanks' Comparison Tool to gauge which firm has the most promising prospects and upside potential over the year ahead. Each health firm has a thumbs up from the analyst community at the time of writing, but which has the most room to run? Let's find out. Abbott Labs (NYSE:ABT) Abbott Labs stock has been trying hard to escape its multi-year rut, with shares now down more than 24% from their late 2021 all-time high of $142.60. Undoubtedly, it's been quite the slog, with the stock giving back all of the gains it enjoyed year-to-date following the most recent 11% correction off h
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Gynecology Collaboration, R&D, and Licensing Deals Trends Report 2024 [Yahoo! Finance]Yahoo! Finance
- BioPorto A/S Appoints President and CEO of BioPorto Inc. [Yahoo! Finance]Yahoo! Finance
- RTD Beverages Market to Reach $1,582.7 Billion by 2031 - Exclusive Report by Meticulous Research® [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Buy AbbVie Stock on the Dip [Yahoo! Finance]Yahoo! Finance
- Implantable Medical Device Market To Reach USD 218.1 Billion By 2032 | DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/2/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/30/24 - Form 4
- ABT's page on the SEC website